New tool helps black and latina women weigh breast MRI options

NCT ID NCT06892275

Recruiting now Knowledge-focused Sponsor: Georgetown University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a decision aid designed to help Black and Latina women at high risk for breast cancer make informed choices about whether to get a breast MRI in addition to their yearly mammogram. Eighty participants will be randomly assigned to receive either standard risk information plus a nurse referral, or that same information plus a detailed decision aid. The goal is to see if the decision aid helps women make choices that match their personal values and knowledge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: decision aid (educational tool)
What this could lead to: If successful, this could help high-risk women make more informed, preference-based decisions about whether to add breast MRI to their annual mammogram.
What could go wrong: This is a small, early-stage behavioral study (80 participants) focused on decision-making, not on health outcomes. The results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm hereditary breast ovarian cancer syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASM FEMALE EARLY DETECTION OF CANCER HEREDITARY BREAST AND OVARIAN CANCER SYNDROME MAGNETIC RESONANCE IMAGING

Contacts and locations

Locations

Georgetown University
RECRUITING

Washington D.C., District of Columbia, 20007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.